This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Nordic
Life Science Executive Partnering
19-20 May 2026Radisson Blu Scandinavia Hotel, Copenhagen, Denmark
Tickets
Menu
Tickets
keyboard_arrow_right

Day One - CET (Central European Time, GMT+01:00)

keyboard_arrow_leftSearch & Filter
search
Day One - CET (Central European Time, GMT+01:00)
search
Showing 1 of 1 Streams
10:40 - 11:20
Breaking Barriers: Unlocking the Potential of Women’s Health Innovation
  • Anette Steenberg - CEO, Medicon Valley Alliance
  • Annette Säfholm - CEO, Gedea Biotech
  • Sana Alajmovic - Co-Founder & CEO, Sigrid Therapeutics
11:20 - 12:00
From Insights to Innovation: Harnessing Disease Biology and New Modalities in Drug Development
  • Claudio Costa-Neto - CSO, Jeito
  • Willem van Weperen - CEO, Pluvia Biotech
  • Antti Vuolanto - CEO, Herantis Pharma Plc
  • Sanne Brun Jensen - Senior Associate, BII
Showing 1 of 1 Streams
13:10 - 14:00
Scaling Success: Key Drivers for Growing Nordic Biotechs
  • Renee Aguiar-Lucander - Chief Executive Officer, Hansa Biopharma
  • Claus Andersson - General Partner, Sunstone Life Science Ventures
  • Hans T. Schambye - Chair of Dansk Biotek, CEO & President of Galecto, Galecto
  • Colleen Acosta - CEO & Co-Founder, Freya Biosciences
  • Johanna Roostalu - Director, Human Health, Venture Creation, BII
14:00 - 14:50
Building the Future: Attracting Top Talent to Nordic and Baltic Life Sciences
  • Sofie Lorentzen - Chief People Officer, BII
  • Kristofer Klerfalk - Entrepreneur, Managing Partner, Life Science Invest
  • Agnė Vaitkevičienė - Vice President, LithuaniaBIO
  • Gražina Mykolaitytė - CEO, VUGENE
Showing 1 of 1 Streams
15:20 - 16:10
Attracting International Investment to Nordic Life Sciences and Examining Late-Stage Opportunities
  • Christina Takke - Managing Partner, V-Bio Ventures
  • Bill Hicks - Partner, Co-Chair of Securities & Capital Markets Group, Mintz
  • Thomas Thestrup - Senior Principal, Angelini Ventures
  • Ivan Burkov - Partner, INKEF Capital
  • Giovanni Rizzo - Partner Biotech Fund, Indaco Venture Partners
16:10 - 17:00
Nordic Deal-Making in 2026: Driving Strategic Partnerships and Growth

As the Nordic region continues to attract global attention, 2026 presents a dynamic environment for deal-making, with companies seeking innovative ways to drive growth and create value. Beyond traditional M&A, strategic partnerships, joint ventures, and licensing agreements are becoming critical tools for companies to achieve their objectives in a competitive global market. This panel will explore the evolving deal-making landscape in the Nordics, the trends shaping strategic collaborations, and the approaches companies can adopt to unlock long-term value through innovative agreements and partnerships.

  • What trends are shaping the Nordic deal-making landscape in 2026, and how can companies adapt their strategies to stay competitive?

  • How can Nordic companies leverage strategic partnerships and collaborations to drive sustainable growth and global market access?

  • What lessons from recent successful deals can inform effective negotiation and execution strategies in 2026?

  • Nuno Alves - Business Development Lead, Astellas Pharm
  • Rasmus Just - Global Head, Business Development, M&A, Licensing, Search & Evaluation, ALK
NextDay One - Showcases
Filter
Streams
Clear
Formats
Choose Day